HeadStART: Evaluating the Effectiveness of Community ART Delivery for People Newly Diagnosed With HIV

Recruiting N/A Interventional Study
HIV Infections Hiv
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Any
Study type
Interventional
Purpose
Health Services Research
Participants needed
2,720 (estimated)
Sponsor
University of Washington · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This is a cluster randomized controlled trial at 12 health centers in refugee settlements in Uganda aiming to evaluate effectiveness of expansion of community antiretroviral therapy (ART) delivery to people newly diagnosed with HIV in achieving HIV viral suppression.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Evidence of a personally signed and dated informed consent document indicating that the subject (or a legal representative) has been informed of all pertinent aspects of the study. 2. Subjects who are willing and able to comply with scheduled visits, treatment plan, laborator…
Contacts

Layla Anderson

206-744-5594

anderla@uw.edu

CONTACT

Kelli O'Laughlin, MD, MPH

kolaugh@uw.edu

CONTACT